一种诺莫格拉姆模型用于预测脑髓母细胞瘤患者的预后
1Affiliated Hospital of Qingdao University, Department of Neurosurgery, Qingdao, China.
Turkish neurosurgery
|June 13, 2023
概括
瘤扩展和治疗方式显著影响心髓母细胞瘤 (MB) 的存活率. 这些因素被用来创建一个名谱模型,用于预测MB患者的癌症特异性生存率.
科学领域:
- 儿科瘤学 儿科瘤学
- 神经瘤学神经瘤学
- 癌症预后 癌症预后
背景情况:
- 脑髓母细胞瘤 (MB) 是儿童的一种主要脑瘤.
- 确定预后因素对于改善患者的治疗结果至关重要.
- 预测模型可以帮助制定个性化治疗策略.
研究的目的:
- 为了确定脑髓母细胞瘤癌症特异性存活率的预后因素.
- 为预测脑髓母细胞瘤存活率开发一个名图模型.
主要方法:
- 来自监测,流行病学和最终结果数据库 (1988-2015) 的268名脑髓母细胞瘤患者的分析.
- 使用考克斯回归分析来确定预后因素.
- 使用C指数,AUC和校准曲线进行模型验证.
主要成果:
- 瘤扩张和治疗方式被确定为脑髓母细胞瘤的显著预后因素.
- 开发的诺米图表表现出预测能力,AUC值分别为0.649,0.629和0.64在2,3和5年.
- 特定的治疗序列,如手术后的辐射和化疗,与改善的预后有关.
结论:
- 瘤扩展和治疗方式是脑髓母细胞瘤的独立预后因素.
- 建立的诺米图为预测MB患者癌症特异性存活率提供了一个工具.
- 结果可以为临床决策和患者咨询提供信息.
相关概念视频
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


